This is a Validated Antibody Database (VAD) review about Rhesus mon.. TNFRSF9, based on 9 published articles (read how Labome selects the articles), using TNFRSF9 antibody in all methods. It is aimed to help Labome visitors find the most suited TNFRSF9 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TNFRSF9 synonym: tumor necrosis factor receptor superfamily member 9; tumor necrosis factor receptor superfamily, member 9

BioLegend
mouse monoclonal (4B4-1)
  • flow cytometry; human; loading ...; fig s2b
BioLegend TNFRSF9 antibody (Biolegend, 4B4-1) was used in flow cytometry on human samples (fig s2b). Nat Med (2019) ncbi
mouse monoclonal (4B4-1)
  • flow cytometry; human; loading ...; fig s1c
BioLegend TNFRSF9 antibody (BioLegend, VI C-7) was used in flow cytometry on human samples (fig s1c). J Immunol (2017) ncbi
mouse monoclonal (4B4-1)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend TNFRSF9 antibody (BioLegend, 4B4-1) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (4B4-1)
  • flow cytometry; human; loading ...; fig 2a
BioLegend TNFRSF9 antibody (BioLegend, n4b4-1) was used in flow cytometry on human samples (fig 2a). elife (2017) ncbi
mouse monoclonal (4B4-1)
  • flow cytometry; human; loading ...; fig 1a
In order to evaluate the predictive values of the protective T-cell response for human cytomegalovirus disease, BioLegend TNFRSF9 antibody (BioLegend, 4B4-1) was used in flow cytometry on human samples (fig 1a). New Microbiol (2016) ncbi
mouse monoclonal (4B4-1)
  • flow cytometry; human; fig 6
BioLegend TNFRSF9 antibody (BioLegend, 4B4-1) was used in flow cytometry on human samples (fig 6). J Immunol Methods (2016) ncbi
mouse monoclonal (4B4-1)
  • immunocytochemistry; human; fig 1
BioLegend TNFRSF9 antibody (BioLegend, 309817) was used in immunocytochemistry on human samples (fig 1). Clin Cancer Res (2015) ncbi
mouse monoclonal (4B4-1)
  • blocking or activating experiments; human; 10 ug/ml; fig 4
BioLegend TNFRSF9 antibody (Biolegend, 4b4-1) was used in blocking or activating experiments on human samples at 10 ug/ml (fig 4). J Virol (2015) ncbi
mouse monoclonal (4B4-1)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend TNFRSF9 antibody (Biolegend, 4B4-1) was used in flow cytometry on human samples . Blood (2014) ncbi
Articles Reviewed
  1. Scheper W, Kelderman S, Fanchi L, Linnemann C, Bendle G, de Rooij M, et al. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat Med. 2019;25:89-94 pubmed publisher
  2. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed publisher
  3. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  4. Lepore M, Kalinichenko A, Calogero S, Kumar P, Paleja B, Schmaler M, et al. Functionally diverse human T cells recognize non-microbial antigens presented by MR1. elife. 2017;6: pubmed publisher
  5. Gabanti E, Bruno F, Scaramuzzi L, Mangione F, Zelini P, Gerna G, et al. Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli. New Microbiol. 2016;39:247-258 pubmed
  6. Jutz S, Leitner J, Schmetterer K, Doel Perez I, Majdic O, Grabmeier Pfistershammer K, et al. Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-κB, NFAT and AP-1. J Immunol Methods. 2016;430:10-20 pubmed publisher
  7. Chacon J, Sarnaik A, Chen J, Creasy C, Kale C, Robinson J, et al. Manipulating the tumor microenvironment ex vivo for enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy. Clin Cancer Res. 2015;21:611-21 pubmed publisher
  8. Flinsenberg T, Spel L, Jansen M, Koning D, de Haar C, Plantinga M, et al. Cognate CD4 T-cell licensing of dendritic cells heralds anti-cytomegalovirus CD8 T-cell immunity after human allogeneic umbilical cord blood transplantation. J Virol. 2015;89:1058-69 pubmed publisher
  9. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher